Fulgent Genetics, Inc. (FLGT)

USD 20.54

(19.07%)

Long Term Debt Summary of Fulgent Genetics, Inc.

  • Fulgent Genetics, Inc.'s latest annual long term debt in 2023 was 10.11 Million USD , down -16.9% from previous year.
  • Fulgent Genetics, Inc.'s latest quarterly long term debt in 2024 Q1 was 1.87 Million USD , down -15.89% from previous quarter.
  • Fulgent Genetics, Inc. reported annual long term debt of 12.16 Million USD in 2022, up 80.47% from previous year.
  • Fulgent Genetics, Inc. reported annual long term debt of 6.74 Million USD in 2021, up 1086.97% from previous year.
  • Fulgent Genetics, Inc. reported quarterly long term debt of 2.49 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Fulgent Genetics, Inc. reported quarterly long term debt of 12.4 Million USD for 2023 Q2, up 313.63% from previous quarter.

Annual Long Term Debt Chart of Fulgent Genetics, Inc. (2023 - 2001)

Historical Annual Long Term Debt of Fulgent Genetics, Inc. (2023 - 2001)

Year Long Term Debt Long Term Debt Growth
2023 10.11 Million USD -16.9%
2022 12.16 Million USD 80.47%
2021 6.74 Million USD 1086.97%
2020 568 Thousand USD -74.82%
2019 2.25 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2001 - USD 0.0%

Peer Long Term Debt Comparison of Fulgent Genetics, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD -228.92%
Applied DNA Sciences, Inc. 739.16 Thousand USD -1267.9%
Aspira Women's Health Inc. 1.43 Million USD -607.063%
Biodesix, Inc. 35.22 Million USD 71.296%
BioNexus Gene Lab Corp. 98.76 Thousand USD -10137.64%
bioAffinity Technologies, Inc. 1.11 Million USD -804.004%
bioAffinity Technologies, Inc. 1.11 Million USD -804.004%
Bionano Genomics, Inc. 7.17 Million USD -40.92%
CareDx, Inc 28.27 Million USD 64.244%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 14.19 Million USD 28.786%
DarioHealth Corp. 24.59 Million USD 58.883%
Exact Sciences Corporation 2.47 Billion USD 99.592%
Guardant Health, Inc. 1.13 Billion USD 99.113%
ICON Public Limited Company 3.66 Billion USD 99.724%
IDEXX Laboratories, Inc. 622.88 Million USD 98.377%
Illumina, Inc. 1.48 Billion USD 99.321%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -12332.984%
iSpecimen Inc. 29.13 Thousand USD -34609.921%
Standard BioTools Inc. 3.98 Million USD -153.854%
MDxHealth SA 35.56 Million USD 71.57%
23andMe Holding Co. 67.84 Million USD 85.097%
Medpace Holdings, Inc. 142.12 Million USD 92.886%
Myriad Genetics, Inc. 130.9 Million USD 92.276%
Mainz Biomed B.V. 2.19 Million USD -360.451%
ENDRA Life Sciences Inc. 192.06 Thousand USD -5164.446%
NeoGenomics, Inc. 606.06 Million USD 98.332%
Neogen Corporation 888.39 Million USD 98.862%
Inotiv, Inc. 399.4 Million USD 97.469%
Natera, Inc. 282.94 Million USD 96.427%
OPKO Health, Inc. 222.03 Million USD 95.446%
Psychemedics Corporation 945 Thousand USD -969.947%
Prenetics Global Limited 867.21 Thousand USD -1065.916%
Prenetics Global Limited 867.21 Thousand USD -1065.916%
Precipio, Inc. 106 Thousand USD -9438.679%
Personalis, Inc. 1.23 Million USD -719.368%
RadNet, Inc. 812.06 Million USD 98.755%
Sera Prognostics, Inc. 840 Thousand USD -1103.69%
Sotera Health Company 2.22 Billion USD 99.545%
Neuronetics, Inc. 59.28 Million USD 82.945%
Star Equity Holdings, Inc. 1.14 Million USD -783.057%
Star Equity Holdings, Inc. 1.14 Million USD -783.057%
Trinity Biotech plc 54.65 Million USD 81.499%
Twist Bioscience Corporation 79.17 Million USD 87.229%
Exagen Inc. 19.23 Million USD 47.423%